In the current study, our results showed that JR pretreatment partly blocked TGFβ1-induced phosphorylation of Smad2/3, indicating JR may inhibit TGFβ1-induced EMT in hepatoma cells through Smad2/3-dependent pathway. Here, TGFB1 is linked to hepatocellular carcinoma.